Phoenix Biotech Acquisition Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Phoenix Biotech Acquisition Corp. generated cash of -$1,092,247, which is less than the previous year. Cash used in financing activities reached the amount of -$138,703,878 last year. Net change in cash is therefore $41,043,271.
Cash Flow
| 2021 | -697.10K | -178.5M | 180.29M |
|---|---|---|---|
| 2022 | -1.09M | 180.83M | -138.70M |
PBAXU Cash Flow Statement (2021 – 2022)
| 2022 | 2021 | |
|---|---|---|
Cash at beginning of period | 1.09M | 0 |
Operating activities | ||
Net income | -667.73K | -315.54K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
| Deferred income tax benefit | 0 | 0 |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable | 1.63M | 0 |
Cash generated by operating activities | -1.09M | -697.10K |
Investing activities | ||
Purchases Of Investments | -325K | -178.5M |
Investments In Property Plant And Equipment | 0 | 0 |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | 180.83M | -178.5M |
Financing activities | ||
Common Stock Issued | 0 | 180.29M |
Payments for dividends | 0 | 0 |
Repurchases of common stock | -139.35M | 0 |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | -138.70M | 180.29M |
Net Change In Cash | 41.04M | 1.09M |
Cash at end of period | 42.14M | 1.09M |
| Data source | Data source |